306 related articles for article (PubMed ID: 15275820)
1. Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids as potential new therapy for the treatment of gliomas.
Parolaro D; Massi P
Expert Rev Neurother; 2008 Jan; 8(1):37-49. PubMed ID: 18088200
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C; González-Feria L; Alvarez L; Haro A; Casanova ML; Guzmán M
Cancer Res; 2004 Aug; 64(16):5617-23. PubMed ID: 15313899
[TBL] [Abstract][Full Text] [Related]
4. High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
Widmer M; Hanemann CO; Zajicek J
J Neurosci Res; 2008 Nov; 86(14):3212-20. PubMed ID: 18615640
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids for cancer treatment: progress and promise.
Sarfaraz S; Adhami VM; Syed DN; Afaq F; Mukhtar H
Cancer Res; 2008 Jan; 68(2):339-42. PubMed ID: 18199524
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in malignant glioma--a target for antitumor therapy?
Tuettenberg J; Friedel C; Vajkoczy P
Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
[TBL] [Abstract][Full Text] [Related]
7. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptors in human astroglial tumors.
Held-Feindt J; Dörner L; Sahan G; Mehdorn HM; Mentlein R
J Neurochem; 2006 Aug; 98(3):886-93. PubMed ID: 16893424
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and gliomas.
Velasco G; Carracedo A; Blázquez C; Lorente M; Aguado T; Haro A; Sánchez C; Galve-Roperh I; Guzmán M
Mol Neurobiol; 2007 Aug; 36(1):60-7. PubMed ID: 17952650
[TBL] [Abstract][Full Text] [Related]
10. Pot of gold for glioma therapy.
Piomelli D
Nat Med; 2000 Mar; 6(3):255-6. PubMed ID: 10700220
[No Abstract] [Full Text] [Related]
11. Cannabinoids and ceramide: two lipids acting hand-by-hand.
Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Haro A; Guzmán M
Life Sci; 2005 Aug; 77(14):1723-31. PubMed ID: 15958274
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids as potential anti-epileptic drugs.
Smith PF
Curr Opin Investig Drugs; 2005 Jul; 6(7):680-5. PubMed ID: 16044663
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid signaling in glioma cells.
Ellert-Miklaszewska A; Ciechomska I; Kaminska B
Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
Zhang T; Guan M; Xu C; Chen Y; Lu Y
Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
17. Treating gliomas with glucocorticoids: from bedside to bench.
Piette C; Munaut C; Foidart JM; Deprez M
Acta Neuropathol; 2006 Dec; 112(6):651-64. PubMed ID: 16855833
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
Pushkarev VM; Kovzun OI; Tronko MD
Exp Oncol; 2008 Mar; 30(1):6-21. PubMed ID: 18438336
[TBL] [Abstract][Full Text] [Related]
19. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
20. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
